Last updated: 04/26/2015, 8:56 PM UTC
Robert W. Baird Reaffirms Outperform Rating on Newlink Genetics Cor (NLNK)Jags ReportRobert W. Baird reissued their outperform rating on shares of Newlink Genetics Cor (NASDAQ: NLNK) in a report released on Monday. Robert W. Baird currently has a $20.00 target price on the stock. Separately, analysts at MLV Capital initiated coverage ...and moreÂ Â»…
Be the first to comment on Robert W. Baird Reaffirms Outperform Rating on Newlink Genetics Cor (NLNK) - Jags Report
Market data delayed 15 minutes.
This site is powered by PassFail. Ideas and opinions presented on this website are for informational and educational purposes only, and do not reflect the opinions of PassFail, or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice.
© 2015 Data provided by Morningstar® Read Full Disclaimer.
Discover and explore public mutual funds with innovative sort and filter features. Add funds to your personal portfolio and watchlists.